362 related articles for article (PubMed ID: 33788387)
1. RAGE: A potential therapeutic target during FGF1 treatment of diabetes-mediated liver injury.
Zheng P; Tang Z; Xiong J; Wang B; Xu J; Chen L; Cai S; Wu C; Ye L; Xu K; Chen Z; Wu Y; Xiao J
J Cell Mol Med; 2021 May; 25(10):4776-4785. PubMed ID: 33788387
[TBL] [Abstract][Full Text] [Related]
2. Exogenous fibroblast growth factor 1 ameliorates diabetes-induced cognitive decline via coordinately regulating PI3K/AKT signaling and PERK signaling.
Wu Y; Wu C; Ye L; Wang B; Yuan Y; Liu Y; Zheng P; Xiong J; Li Y; Jiang T; Li X; Xiao J
Cell Commun Signal; 2020 May; 18(1):81. PubMed ID: 32460803
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 1 ameliorates diabetes-induced splenomegaly via suppressing inflammation and oxidative stress.
Wu Y; Jia G; Wang B; Xiong J; Xu J; Zheng P; Yuan Y; Li Y; Jiang T; Al Mamun A; Xu K; Liu Y; Cao H; Xiao J
Biochem Biophys Res Commun; 2020 Jul; 528(2):249-255. PubMed ID: 32482386
[TBL] [Abstract][Full Text] [Related]
4. Naringin ameliorates type 2 diabetes mellitus-induced steatohepatitis by inhibiting RAGE/NF-κB mediated mitochondrial apoptosis.
Syed AA; Reza MI; Shafiq M; Kumariya S; Singh P; Husain A; Hanif K; Gayen JR
Life Sci; 2020 Sep; 257():118118. PubMed ID: 32702445
[TBL] [Abstract][Full Text] [Related]
5. Olmesartan attenuates type 2 diabetes-associated liver injury: Cross-talk of AGE/RAGE/JNK, STAT3/SCOS3 and RAS signaling pathways.
Abo El-Nasr NME; Saleh DO; Mahmoud SS; Nofal SM; Abdelsalam RM; Safar MM; El-Abhar HS
Eur J Pharmacol; 2020 May; 874():173010. PubMed ID: 32067934
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 1 ameliorates adipose tissue inflammation and systemic insulin resistance via enhancing adipocyte mTORC2/Rictor signal.
Zhao L; Fan M; Zhao L; Yun H; Yang Y; Wang C; Qin D
J Cell Mol Med; 2020 Nov; 24(21):12813-12825. PubMed ID: 32979037
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of catalpol on diabetes mellitus-induced male reproductive damage via suppression of the AGEs/RAGE/Nox4 signaling pathway.
Jiao N; Chen Y; Zhu Y; Wang W; Liu M; Ding W; Lv G; Lu J; Yu B; Xu H
Life Sci; 2020 Sep; 256():116736. PubMed ID: 31398417
[TBL] [Abstract][Full Text] [Related]
8. Irbesartan attenuates advanced glycation end products-mediated damage in diabetes-associated osteoporosis through the AGEs/RAGE pathway.
Cheng YZ; Yang SL; Wang JY; Ye M; Zhuo XY; Wang LT; Chen H; Zhang H; Yang L
Life Sci; 2018 Jul; 205():184-192. PubMed ID: 29702126
[TBL] [Abstract][Full Text] [Related]
9. DNA aptamer raised against receptor for advanced glycation end products suppresses renal tubular damage and improves insulin resistance in diabetic mice.
Sotokawauchi A; Matsui T; Higashimoto Y; Nishino Y; Koga Y; Yagi M; Yamagishi SI
Diab Vasc Dis Res; 2021; 18(1):1479164121990533. PubMed ID: 33535822
[TBL] [Abstract][Full Text] [Related]
10. FGF1
Lin Q; Chen O; Wise JP; Shi H; Wintergerst KA; Cai L; Tan Y
Biochim Biophys Acta Mol Basis Dis; 2022 Aug; 1868(8):166414. PubMed ID: 35447340
[TBL] [Abstract][Full Text] [Related]
11. S100A9-RAGE Axis Accelerates Formation of Macrophage-Mediated Extracellular Vesicle Microcalcification in Diabetes Mellitus.
Kawakami R; Katsuki S; Travers R; Romero DC; Becker-Greene D; Passos LSA; Higashi H; Blaser MC; Sukhova GK; Buttigieg J; Kopriva D; Schmidt AM; Anderson DG; Singh SA; Cardoso L; Weinbaum S; Libby P; Aikawa M; Croce K; Aikawa E
Arterioscler Thromb Vasc Biol; 2020 Aug; 40(8):1838-1853. PubMed ID: 32460581
[TBL] [Abstract][Full Text] [Related]
12. RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes.
Wendt T; Harja E; Bucciarelli L; Qu W; Lu Y; Rong LL; Jenkins DG; Stein G; Schmidt AM; Yan SF
Atherosclerosis; 2006 Mar; 185(1):70-7. PubMed ID: 16076470
[TBL] [Abstract][Full Text] [Related]
13. The Receptor for Advanced Glycation Endproducts (RAGE) Contributes to Severe Inflammatory Liver Injury in Mice.
Weinhage T; Wirth T; Schütz P; Becker P; Lueken A; Skryabin BV; Wittkowski H; Foell D
Front Immunol; 2020; 11():1157. PubMed ID: 32670276
[No Abstract] [Full Text] [Related]
14. Induction of receptor for advanced glycation end products by insufficient leptin action triggers pancreatic β-cell failure in type 2 diabetes.
Han D; Yamamoto Y; Munesue S; Motoyoshi S; Saito H; Win MT; Watanabe T; Tsuneyama K; Yamamoto H
Genes Cells; 2013 Apr; 18(4):302-14. PubMed ID: 23410183
[TBL] [Abstract][Full Text] [Related]
15. Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer.
Suh JM; Jonker JW; Ahmadian M; Goetz R; Lackey D; Osborn O; Huang Z; Liu W; Yoshihara E; van Dijk TH; Havinga R; Fan W; Yin YQ; Yu RT; Liddle C; Atkins AR; Olefsky JM; Mohammadi M; Downes M; Evans RM
Nature; 2014 Sep; 513(7518):436-9. PubMed ID: 25043058
[TBL] [Abstract][Full Text] [Related]
16. Effects of candesartan cilexetil and amlodipine orotate on receptor for advanced glycation end products expression in the aortic wall of Otsuka Long-Evans Tokushima Fatty (OETFF) type 2 diabetic rats.
Kang MK; Chung WB; Hong SK; Kim OR; Ihm SH; Chang K; Seung KB
Arch Pharm Res; 2016 Apr; 39(4):565-576. PubMed ID: 26960737
[TBL] [Abstract][Full Text] [Related]
17. Production and application of HMGB1 derived recombinant RAGE-antagonist peptide for anti-inflammatory therapy in acute lung injury.
Lee S; Piao C; Kim G; Kim JY; Choi E; Lee M
Eur J Pharm Sci; 2018 Mar; 114():275-284. PubMed ID: 29292016
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast Growth Factor 1 Ameliorates Diabetes-Induced Liver Injury by Reducing Cellular Stress and Restoring Autophagy.
Xu Z; Wu Y; Wang F; Li X; Wang P; Li Y; Wu J; Li Y; Jiang T; Pan X; Zhang X; Xie L; Xiao J; Liu Y
Front Pharmacol; 2020; 11():52. PubMed ID: 32194395
[TBL] [Abstract][Full Text] [Related]
19. RAGE inhibition reduces acute lung injury in mice.
Blondonnet R; Audard J; Belville C; Clairefond G; Lutz J; Bouvier D; Roszyk L; Gross C; Lavergne M; Fournet M; Blanchon L; Vachias C; Damon-Soubeyrand C; Sapin V; Constantin JM; Jabaudon M
Sci Rep; 2017 Aug; 7(1):7208. PubMed ID: 28775380
[TBL] [Abstract][Full Text] [Related]
20. A monoclonal antibody against the receptor for advanced glycation end products attenuates inflammatory and neuropathic pain in the mouse.
Brederson JD; Strakhova M; Mills C; Barlow E; Meyer A; Nimmrich V; Leddy M; Simler G; Schmidt M; Jarvis M; Lacy S
Eur J Pain; 2016 Apr; 20(4):607-14. PubMed ID: 26392119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
